Načítá se...
Bone marrow stromal cells as a therapeutic treatment for ischemic stroke
Cerebral ischemia remains the most frequent cause of death and quality-of-life impairments due to neurological deficits, and accounts for the majority of total healthcare costs. However, treatments for cerebral ischemia are limited. Over the last decade, bone marrow stromal cell (BMSC) therapy has e...
Uloženo v:
| Vydáno v: | Neurosci Bull |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5562610/ https://ncbi.nlm.nih.gov/pubmed/24817388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12264-013-1431-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|